JP2023540441A5 - - Google Patents
Info
- Publication number
- JP2023540441A5 JP2023540441A5 JP2023507726A JP2023507726A JP2023540441A5 JP 2023540441 A5 JP2023540441 A5 JP 2023540441A5 JP 2023507726 A JP2023507726 A JP 2023507726A JP 2023507726 A JP2023507726 A JP 2023507726A JP 2023540441 A5 JP2023540441 A5 JP 2023540441A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- vector
- nucleic acid
- cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063060353P | 2020-08-03 | 2020-08-03 | |
| US63/060,353 | 2020-08-03 | ||
| PCT/US2021/044351 WO2022031708A1 (en) | 2020-08-03 | 2021-08-03 | Aav vectors encoding parkin and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540441A JP2023540441A (ja) | 2023-09-25 |
| JP2023540441A5 true JP2023540441A5 (https=) | 2024-08-09 |
Family
ID=80118490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507726A Pending JP2023540441A (ja) | 2020-08-03 | 2021-08-03 | Ｐａｒｋｉｎをコードするａａｖベクターおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230304036A1 (https=) |
| EP (1) | EP4189097A4 (https=) |
| JP (1) | JP2023540441A (https=) |
| KR (1) | KR20230043181A (https=) |
| CN (1) | CN116113701A (https=) |
| AU (1) | AU2021322113A1 (https=) |
| BR (1) | BR112023001788A2 (https=) |
| CA (1) | CA3190720A1 (https=) |
| IL (1) | IL300219A (https=) |
| MX (1) | MX2023001565A (https=) |
| WO (1) | WO2022031708A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1504108T1 (sl) * | 2002-02-01 | 2013-07-31 | Oxford Biomedica (Uk) Limited | Lentiviralni vektor |
| WO2013151665A2 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| EP3622291A4 (en) * | 2017-05-10 | 2021-04-21 | Rowan University | Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis |
| BR112020006661A2 (pt) * | 2017-10-03 | 2020-10-13 | Prevail Therapeutics, Inc. | terapias de genes para distúrbios lipossomais |
| MX2020011386A (es) * | 2018-04-27 | 2021-01-29 | Spacecraft Seven Llc | Terapia genica para la degeneracion del snc. |
-
2021
- 2021-08-03 BR BR112023001788A patent/BR112023001788A2/pt unknown
- 2021-08-03 JP JP2023507726A patent/JP2023540441A/ja active Pending
- 2021-08-03 CN CN202180057979.4A patent/CN116113701A/zh active Pending
- 2021-08-03 WO PCT/US2021/044351 patent/WO2022031708A1/en not_active Ceased
- 2021-08-03 EP EP21852310.8A patent/EP4189097A4/en not_active Withdrawn
- 2021-08-03 MX MX2023001565A patent/MX2023001565A/es unknown
- 2021-08-03 US US18/019,357 patent/US20230304036A1/en active Pending
- 2021-08-03 IL IL300219A patent/IL300219A/en unknown
- 2021-08-03 AU AU2021322113A patent/AU2021322113A1/en active Pending
- 2021-08-03 KR KR1020237006437A patent/KR20230043181A/ko not_active Withdrawn
- 2021-08-03 CA CA3190720A patent/CA3190720A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022060228A5 (https=) | ||
| US5858351A (en) | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors | |
| US20240197918A1 (en) | Tissue-targeted modified aav capsids and methods of use thereof | |
| JP2022549380A5 (https=) | ||
| JP2020537543A5 (https=) | ||
| JP2020537544A5 (https=) | ||
| JP2020537542A5 (https=) | ||
| JP2022508182A5 (https=) | ||
| EP4182467B1 (en) | Recombinant adeno-associated viral vectors for multipartite gene delivery | |
| US12077772B2 (en) | Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-optimized SLC6A1 | |
| US12534741B2 (en) | Compositions and methods for treatment of neurological disorders | |
| US20250283111A1 (en) | Recombinant adeno-associated viral vector for gene delivery | |
| US12270033B2 (en) | Dual leucine zipper kinase inhibitors for gene therapy | |
| JP2021520811A5 (https=) | ||
| JP2021534766A5 (https=) | ||
| AU2023406927A1 (en) | Adeno-associated viral vectors for proper packaging of repetitive elements | |
| JP2023540441A5 (https=) | ||
| US20240342314A1 (en) | Slc13a5 gene therapy vectors and uses thereof | |
| JP2025515030A5 (https=) | ||
| KR102874560B1 (ko) | 아데노연관바이러스 변이체 | |
| CN118019855A (zh) | Slc13a5基因治疗载体及其用途 | |
| HK40115114A (zh) | 针对鞘内给药优化的导入肝细胞生长因子基因的aav载体 | |
| RU2022111695A (ru) | Выделенная нуклеиновая кислота, которая кодирует слитый белок на основе FVIII-BDD и гетерологичного сигнального пептида, и ее применение | |
| EA051405B1 (ru) | Векторы на основе аденассоциированного вируса для лечения болезни хантера |